Monophosphoryl lipid A (MPL) promotes allergen-induced immune deviation in favour of Th1 responses. (Q40511372)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813815%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Monophosphoryl lipid A (MPL) promotes allergen-induced immune deviation in favour of Th1 responses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813815%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813815%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Durham SR

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813815%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Francis JN

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813815%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 May 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813815%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813815%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813815%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

678-684

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813815%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813815%20AND%20SRC:MED&resulttype=core&format=json

Long-term clinical efficacy of grass-pollen immunotherapy

10 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00762.X

Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00762.X

Grass pollen immunotherapy decreases the number of mast cells in the skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00762.X

Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00762.X

Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00762.X

Enhanced immunogenicity of a recombinant genital warts vaccine adjuvanted with monophosphoryl lipid A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00762.X

Monophosphoryl lipid A and QS21 increase CD8 T lymphocyte cytotoxicity to herpes simplex virus-2 infected cell proteins 4 and 27 through IFN-gamma and IL-12 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00762.X

Safety evaluation of monophosphoryl lipid A (MPL): an immunostimulatory adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00762.X

Safety, immunogenicity, and efficacy of Plasmodium falciparum repeatless circumsporozoite protein vaccine encapsulated in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00762.X

A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00762.X

Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00762.X

A Th1-inducing adjuvant, MPL, enhances antibody profiles in experimental animals suggesting it has the potential to improve the efficacy of allergy vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00762.X

Mechanisms of monophosphoryl lipid A augmentation of host responses to recombinant HagB from Porphyromonas gingivalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00762.X

Selective regulation of intercellular adhesion molecule-1 expression by interleukin-18 and interleukin-12 on human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00762.X

Role of Innate Immune Factors in the Adjuvant Activity of Monophosphoryl Lipid A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00762.X

Immunotherapy: 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00762.X

TLR2 is expressed on activated T cells as a costimulatory receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00762.X

Interleukin-18 plays a role in both the alum-induced T helper 2 response and the T helper 1 response induced by alum-adsorbed interleukin-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00762.X

10.1111/J.1398-9995.2005.00762.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15813815%20AND%20SRC:MED&resulttype=core&format=json

release_vrqpkuyn4beahpfwzkrtlhvnqu

10 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vrqpkuyn4beahpfwzkrtlhvnqu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference